Inactivated Sendai Virus Induces ROS-dependent Apoptosis and Autophagy in Human Prostate Cancer Cells.
- Author:
Miao QIAN
1
,
2
;
Hai Ming TAN
1
,
2
;
Ning YU
1
,
2
;
Tao WANG
1
,
2
;
Quan ZHANG
1
,
2
Author Information
- Publication Type:Journal Article
- Keywords: Apoptosis; Autophagy; Inactivated Sendai virus (HVJ-E); Reactive oxygen species (ROS)
- MeSH: Apoptosis; physiology; Autophagy; physiology; Cell Line, Tumor; Cell Survival; Humans; Male; Oncolytic Virotherapy; Prostatic Neoplasms; metabolism; Reactive Oxygen Species; metabolism; Sendai virus; immunology; physiology; Virus Inactivation
- From: Biomedical and Environmental Sciences 2018;31(4):280-289
- CountryChina
- Language:English
-
Abstract:
OBJECTIVEThe current study aims to investigate the effect of Hemagglutinating virus of Japan envelope (HVJ-E) on induction of apoptosis and autophagy in human prostate cancer PC3 cells, and the underlying mechanisms.
METHODSPC3 cells were treated with HVJ-E at various multiplicity of infection (MOI), and the generated reactive oxygen species (ROS), cell viability, apoptosis, and autophagy were detected, respectively. Next, the role of ROS played in the regulation of HVJ-E-induced apoptosis and autuphagy in PC3 cells were analysed. In the end, the relationship between HVJ-E-induced apoptosis and autuophagy was investigated by using rapamycin and chloroquine.
RESULTSFlow cytometry assay revealed that HVJ-E treatment induced dose-dependent apoptosis and that the JNK and p38 MAPK signaling pathways were involved in HVJ-E-induced apoptosis in PC3 cells. In addition, HVJ-E was able to induce autophagy in PC3 cells via the class III PI3K/beclin-1 pathway. The data also implyed that HVJ-E-triggered autophagy and apoptosis were ROS dependent. When ROS was blocked with N-acetylcysteine (NAC), HVJ-E-induced LC3-II conversion and apoptosis were reversed. Interestingly, HVJ-E-induced apoptosis was significantly increased by an inducer of autophagy, rapamycin pretreatment, both in vitro and in vivo.
CONCLUSIONHVJ-E exerts anticancer effects via autophagic cell death in prostate cancer cells.